Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
12 January 2017
E-000149-17
Question for written answer
to the Commission
Rule 130
Fredrick Federley (ALDE)

 Subject:  The Commission's strategic approach to the contamination of water by pharmaceutical substances
 Answer(s) 

In accordance with Article 8c of Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013, within two years of 13 September 2013 the Commission was to develop a strategic approach to the pollution of water by pharmaceutical substances. Where appropriate, that strategic approach was to include proposals enabling, to the extent necessary, the environmental impact of medicines to be taken into account more effectively in the procedure for placing medicinal products on the market.

It is pointed out in Directive 2013/39/EU that the contamination of water and soil with pharmaceutical residues is an emerging environmental concern, and that the Commission should look into the effects that pharmaceutical products can have on the environment, and provide an analysis of the current rules on protecting the aquatic environment and human health via the aquatic environment.

It is a matter of concern that the Commission has not yet come forward with any plans setting out when the strategic approach will be ready. The approach is needed in order to guarantee a healthy aquatic environment and a good level of animal protection, and to bring down resistance to antibiotics.

In the light of the foregoing, therefore:
1. When is the Commission intending to come forward with the strategic approach to the contamination of water by pharmaceutical products?
2. What does the Commission’s plan look like as regards laying the groundwork for the strategic approach, and where or under whose auspices will the Commission seek to anchor the approach?
Original language of question: SV 
Last updated: 25 January 2017Legal notice